GRIFOLS reported €1.35B in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Alcon AG ALC:SW 2.11B 180M
Amadeus IT AMS:SM € 624.4M 127.7M
Amarin AMRN:US $ 154.49M 12.32M
AstraZeneca AZN:LN 8220M 900M
Bayer BAYN:GR € 10854M 1474M
Essilor EI:FP 4.06B 25M
Ferrovial FER:SM € 1600M 235M
Fresenius FRE:GR € 9246M 262M
Fresenius Medical Care FME:GR € 4320M 110M
Galapagos GLPG:NA € 153.07M 28.91M
Genmab GEN:DC DK 1972M 391M
GlaxoSmithKline GSK:LN 8092M 674M
GRIFOLS GRF:SM € 1351.9M 167.16M
H. Lundbeck A/S LUN:DC 3.96B 313M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Inditex ITX:SM € 6994M 2052M
Merck MRK:GR € 4870M 239M
Novartis NOVN:VX SF 13294M 600M
Philips PHIA:NA € 4230M 403M
William Demant Holding WDH:DC 9.01B 621M